KR102789451B1 - 질산염 보강 조성물 및 이의 사용 방법 - Google Patents

질산염 보강 조성물 및 이의 사용 방법 Download PDF

Info

Publication number
KR102789451B1
KR102789451B1 KR1020217027218A KR20217027218A KR102789451B1 KR 102789451 B1 KR102789451 B1 KR 102789451B1 KR 1020217027218 A KR1020217027218 A KR 1020217027218A KR 20217027218 A KR20217027218 A KR 20217027218A KR 102789451 B1 KR102789451 B1 KR 102789451B1
Authority
KR
South Korea
Prior art keywords
elemental
composition
nitrate
magnesium
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217027218A
Other languages
English (en)
Korean (ko)
Other versions
KR20210119499A (ko
Inventor
알렉산드로스 니콜라이디스
로날드 크래머
Original Assignee
써모라이프 인터내셔널, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 써모라이프 인터내셔널, 엘엘씨 filed Critical 써모라이프 인터내셔널, 엘엘씨
Publication of KR20210119499A publication Critical patent/KR20210119499A/ko
Application granted granted Critical
Publication of KR102789451B1 publication Critical patent/KR102789451B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
KR1020217027218A 2019-02-01 2020-01-31 질산염 보강 조성물 및 이의 사용 방법 Active KR102789451B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962800361P 2019-02-01 2019-02-01
US62/800,361 2019-02-01
US201962866540P 2019-06-25 2019-06-25
US62/866,540 2019-06-25
US16/779,349 2020-01-31
US16/779,349 US20200222449A1 (en) 2019-02-01 2020-01-31 Enhanced Nitrate Compositions and Methods of Use
PCT/US2020/016274 WO2020160509A1 (en) 2019-02-01 2020-01-31 Enhanced nitrate compositions and methods of use

Publications (2)

Publication Number Publication Date
KR20210119499A KR20210119499A (ko) 2021-10-05
KR102789451B1 true KR102789451B1 (ko) 2025-03-31

Family

ID=71517286

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217027218A Active KR102789451B1 (ko) 2019-02-01 2020-01-31 질산염 보강 조성물 및 이의 사용 방법

Country Status (12)

Country Link
US (5) US20200222449A1 (enExample)
EP (1) EP3917543B1 (enExample)
JP (1) JP7534310B2 (enExample)
KR (1) KR102789451B1 (enExample)
CN (1) CN113498345A (enExample)
AU (2) AU2020215729B2 (enExample)
BR (1) BR112021015110A2 (enExample)
CA (1) CA3128232A1 (enExample)
EA (1) EA202192132A1 (enExample)
IL (1) IL285247A (enExample)
MX (1) MX428917B (enExample)
WO (1) WO2020160509A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US12612370B2 (en) 2011-03-02 2026-04-28 Thermolife International, Llc Amino acid compositions
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
JP2024541338A (ja) * 2020-11-12 2024-11-08 サーモライフ インターナショナル， エルエルシー 血中酸素飽和度を増大させる方法
EP4291206A4 (en) * 2021-02-11 2025-01-08 Thermolife International, LLC A method of administering nitric oxide gas
IL305762A (en) * 2021-03-11 2023-11-01 Thermolife Int Llc Compositions including nitrate, metal element and amino acid, and methods of use
US20230057399A1 (en) * 2021-08-16 2023-02-23 Thermolife International, Llc Iron supplement compositions and methods of use thereof
US20240226140A1 (en) * 2023-01-09 2024-07-11 Azulent, Llc Nitric oxide and molecular hydrogen generating compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180133247A1 (en) * 2016-11-15 2018-05-17 Berkeley Nox Limited Novel dietary supplements

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU476799B2 (en) * 1974-02-04 1976-08-05 Carlton And United Breweries Limited Preparation of a water soluble isomerised hop extract
US6703056B2 (en) * 2000-09-29 2004-03-09 The Procter + Gamble Co. Beverage compositions comprising arabinogalactan and defined minerals
US7208170B2 (en) * 2002-09-20 2007-04-24 Petersson Lennart G Powder teat dip germicide, fungicide and skin conditioner
AU2003289208A1 (en) * 2002-12-06 2004-06-30 Kyowa Hakko Kogyo Co., Ltd. Beverage containing amino acid and method of diminishing bitterness of amino acid
CA2678093C (en) * 2007-02-26 2017-10-24 Jon Lundberg Performance enhancing composition and use thereof
US7777074B2 (en) 2007-09-18 2010-08-17 Thermolife International, Llc Amino acid compounds
US10646508B1 (en) * 2007-09-18 2020-05-12 Thermolife International, Llc Method of safely administering nitrate dietary supplements and compositions
WO2009147229A1 (en) * 2008-06-06 2009-12-10 Phytolab Gmbh & Co. Kg Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
ES2538652T3 (es) * 2009-06-16 2015-06-23 Dusan Miljkovic Composiciones y procedimientos para producir un potencial negativo de oxidación-reducción estable en materiales consumibles
JP2014513527A (ja) * 2011-04-21 2014-06-05 ネステク ソシエテ アノニム パフォーマンス向上のための栄養組成物並びにその作製及び使用方法
JP6016610B2 (ja) * 2012-12-20 2016-10-26 江崎グリコ株式会社 筋肉増量用サプリメント
AU2015334553B2 (en) * 2014-10-22 2020-03-05 Innoveco Australia Pty. Ltd. Process for metal extraction with sorption leaching in wet solids
ES2651717B1 (es) * 2016-07-26 2018-11-16 Lara OLLER DUQUE Solución acuosa cristaloide isotónica
US11541020B2 (en) * 2019-04-16 2023-01-03 Thermolife International, Llc Hexylamine salts and methods of using hexylamine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180133247A1 (en) * 2016-11-15 2018-05-17 Berkeley Nox Limited Novel dietary supplements

Also Published As

Publication number Publication date
IL285247A (en) 2021-09-30
EP3917543A4 (en) 2022-10-12
JP7534310B2 (ja) 2024-08-14
KR20210119499A (ko) 2021-10-05
AU2023203649B2 (en) 2024-11-14
BR112021015110A2 (pt) 2022-01-11
EP3917543A1 (en) 2021-12-08
EA202192132A1 (ru) 2021-10-19
US20240122969A1 (en) 2024-04-18
JP2022523513A (ja) 2022-04-25
WO2020160509A1 (en) 2020-08-06
US20240122966A1 (en) 2024-04-18
US20240122968A1 (en) 2024-04-18
MX2021009287A (es) 2021-11-12
AU2023203649A1 (en) 2023-07-06
EP3917543B1 (en) 2026-07-01
US20240122967A1 (en) 2024-04-18
MX428917B (es) 2025-11-13
AU2020215729A1 (en) 2021-09-02
AU2020215729B2 (en) 2023-03-30
US20200222449A1 (en) 2020-07-16
CA3128232A1 (en) 2020-08-06
CN113498345A (zh) 2021-10-12

Similar Documents

Publication Publication Date Title
US20240122969A1 (en) Enhanced nitrate compositions and methods of use
Gonzalez et al. Effects of citrulline supplementation on exercise performance in humans: A review of the current literature
RU2356247C2 (ru) Комбинации и композиции, содержащие жирные кислоты и аминокислоты, их применение для предупреждения, замедления прогрессирования или лечения диабета и связанных с диабетом заболеваний и состояний, способ снижения веса тела млекопитающего, набор
EP2512236B1 (en) Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb)
JP5762396B2 (ja) 糖尿病療法の支援のためのα−ケト酸を含有する栄養補助剤
US10357529B2 (en) Natural formulation for treating hangover
EP2148580A1 (en) Compositions and approaches for increasing diet induced thermogenesis, inducing weight loss and maintaining muscles mass and strength
Maheshwari et al. Latent therapeutic gains of beetroot juice.
WO2009082883A1 (fr) Composition anti-obésité
JP4119629B2 (ja) 高血圧症予防・改善・治療剤
JP6469283B2 (ja) アンモニア代謝促進剤
WO2017206026A1 (zh) 提升运动能力的能量组合物
CN112690457A (zh) 一种用于超重和肥胖人群的营养素组合物配方
EA049159B1 (ru) Улучшенный нитратный состав и способы применения
CN116138450A (zh) 一种含5-氨基乙酰丙酸或其衍生物的运动营养组合物及制备方法和应用
WO2007077995A1 (ja) 筋肉増量剤
US20250000832A1 (en) Enhanced nitrate, elemental metal, and amino acid compositions and methods of use
RU2741079C1 (ru) Пищевая добавка «пребио дкв»
US20250082580A1 (en) Controlled-release oral formulation and preparation method thereof
WO2026095824A1 (en) A combination consisting of resveratrol, curcumin, quercetin and nad precursor, a composition comprising the combination and uses thereof
JP2589112B2 (ja) 酒酔い防止剤
CN114588207A (zh) 一种提高运动耐力和促进运动后恢复的组合物及其应用
CN115721018A (zh) 一种增强耐力的组合物
HK1123483A (en) Compositions for weight loss
WO2002069956A2 (en) Use of carnitine for increasing testosteron

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20210826

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230818

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240806

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20250102

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20250327

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20250327

End annual number: 3

Start annual number: 1

PG1601 Publication of registration